A recent study finds that the risk for myalgic encephalomyelitis/chronic fatigue syndrome is increased following COVID-19.

The majority of working-age patients with postacute sequelae of COVID-19/post-COVID-19 syndrome (PCS) do not recover ...

Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist.

The Covid-19 outbreak in 2020 was on a scale not seen since the Spanish flu pandemic in 1918 and laid bare our lack of ...

A study of nearly 1,000 people with post-COVID-19 syndrome (PCS) revealed that two-thirds still experienced significant symptoms, including reduced exercise capacity and cognitive performance, two ...

The U.S. has traditionally been the most generous benefactor of the WHO. A Trump executive order to cut ties with the WHO ...

Iona Everson from PMGroup speaks to Amar Urhekar, CEO of Avalere Health, about his professional journey within healthcare ...

It is no secret that Womack Army Medical Center is one of the best and busiest military treatment facilities in the world.

In hospitalized COVID-19 patients, azvudine shows lower all-cause mortality and fewer adverse events than Paxlovid, with ...

It was also under development for the treatment of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). AptaBio Therapeutics (AptaBio) is a ...

You will be able to get a quick price and instant permission to reuse the content in many different ways. The acute respiratory distress syndrome (ARDS) is an acute and severe form of microvascular ...